Transce3nd, LLC Astrazeneca PLC Transaction History
Transce3nd, LLC
- $237 Billion
- Q2 2025
A detailed history of Transce3nd, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Transce3nd, LLC holds 25 shares of AZN stock, worth $1,883. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25
Previous 25
-0.0%
Holding current value
$1,883
Previous $1.84 Million
4.95%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,413Shares Held
506MCall Options Held
9.17MPut Options Held
3.07M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$3.91 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.1 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.59 Billion0.45% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.4 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.37 Billion0.39% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $233B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...